Oral HPV Related Diseases: A Review and an Update by dos Reis, Helena Lucia Barroso et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2
Oral HPV Related Diseases: A Review and an Update
Helena Lucia Barroso dos Reis,
Silvia Paula de Oliveira, Danielle Resende Camisasca,
Juliana Bittencourt Pessoa,
Ana Beatriz Azevedo Queiroz,
Mauro Romero Leal Passos, Philippe Godefroy,
Dennis de Carvalho Ferreira,
Thais Camporez Pimentel and
Antonio Chambo Filho
Additional information is available at the end of the chapter
 
1. Introduction
Human papilloma virus (HPV) is responsible for the most common sexually transmitted
infections. It is estimated that two thirds of people who have unprotected sexual intercourse
with a HPV carrier are infected [1].
Since HPV has tropism for epithelial tissue [2-4], it can affect both skin and mucosa [3, 4]. It
causes several types of injuries, ranging from asymptomatic infection and benign warts to
invasive injuries [5]. HPV infection has been found in a wide range of anatomical sites: genital
and anal tract, urethra, upper airway, tracheobronchial mucosa, nasal paranasal cavities, and
oral cavity. HPV on oral mucosa presently afflicts 1% to 43% of the general population,
depending on the diagnosis method used [5], and may be even associated with oral malig‐
nancies [6].
The aim of this review article is to offer the academic community an updated review of HPV,
emphasizing its importance as a public health matter. This review encloses HPV epidemiology,
virology description of different oral lesions, clinical picture, oncogenesis and, diagnostic tools.
We have also reviewed current treatment choices and prophylaxis, as well as vaccines against
HPV.
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. The biology of human papillomavirus — Virion structure
HPV is a small DNA virus belonging to Papillomaviridae family [1, 2, 7, 8]. Its virion consists of
a non enveloped, singular double stranded DNA molecule [5, 8, 9], of about 7.9kb [8], involved
by a capsid, of about 55 nm in diameter [8, 9], containing only two structural proteins [8].
HPV genome presents a notable organization. It weighs 5.2x106D and contains 7.200 – 8.000
pairs of nitrogenous bases (pnb) [9]. All putative open reading frames (ORFs) are limited to
only one strand of DNA [8]. Non-coding strand probably forms a second, which bears pieces
of preserved ORFs, irrespective of localization and composition [8], Chlaudhary et al (2009)
have suggested that the basis of the HPV molecule DNA can be divided in three parts. The
first part, with 4.000 pnb, accounts for viral replication and cell transformation while the second
part, with 3.000 pnb, represents an important codification zone, since it encodes the viral
particle structural proteins. The last one, with only 1.000 pnb, contains a non-coding zone; it
is, however, fundamental, since the viral origin of replication belongs to this part [9].
2.1. Genome structure
The difference of HPV types is due to the variation of E6 and E7 sequence of nitrogenous bases.
This variation can produce either an easier to inhibit gene or a harder to inhibit one, thus
stratifying the virus oncogenic phenotype into high, intermediate and low risk types
[7].Besides its oncogenic potential, the HPV types vary according to tissue tropism and their
association with these tissues [10]. Over a 100 HPV types [7] have been identified, but only 25
(HPV - 1, 2, 3, 4, 6, 7, 10, 11, 13, 16, 18, 31, 32, 33, 35, 40, 45, 52, 55, 57, 58, 59, 69, 72, 73) were
associated with benign or malignant lesions [3, 10]. Low-risk HPV (6, 11, 38, 40, 42, 54, 55, 61,
62, 64, 67, 69, 70, 71, 72, 81, 83, 84, 89) [11] causes injuries which produce abnormal cell growth
[8]; however, they are unlikely to undergo malignant neoplastic transformation. High-risk
HPV (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) [11] are likely to induce
malignant neoplastic transformation [3, 11]. Recently HPV- 26, 53, 66 have been found to be
among the potentially high-risk types [12].
HPV - 6, 11 are related to condyloma acuminatum and, in children, laryngeal papilloma,
conjuntival papilloma and genital warts [13]. HPV – 16, 18, mainly, but also 31, 32 and 35 are
associated with squamous cell carcinoma [11]. Although benign forms rarely developed into
malignant, they can concurrently present with the high-risk malignant injury [9].
3. Prevalence and incidence
The American Cancer Society has estimated that more than 6 million people are infected by
HPV each year, with 3 million affecting the 15- 25 age group [14].
Asymptomatic oral and oropharynx HPV prevalence at oral cavity has not yet been established
[15], probably because different methods were used in different studies [3]. Methods have
varied in terms of size of samples, collecting procedures, test sensibility and use of PCR or PCR
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inhibitors. This may explain the huge variation in HPV detection rate: 22 to 60% or 0 to 81.1%,
depending on the methods and on the studied population [15].
Recent meta-analysis has demonstrated that HPV is an isolated risk factor for the development
of oral carcinoma [2]. Oral squamous cell carcinoma is known to be linked with both heavy
drinking and smoking and it has been related to HPV [6, 7].
3.1. Oral human papillomavirus infection
When oral mucosa is considered normal, the epithelium may serve as a container of HPV which
would be activated at some point in time and induce injury [16]. A huge number of different
oral diseases may be associated with oral HPV, but they rarely cause lesions [17]. Lesions may
range from benign warts, which are far more common, to malignant injuries [6].
3.2. Sexual and nonsexual transmission
Many studies have discussed HPV transmission, but the mechanisms involved remain
unknown. Unprotected sexual intercourse is its leading cause, particularly oral-genital sex,
when the genital mucosa is infected by the virus, which will be present both clinically and
subclinically [1, 16] in adolescent and adults. Early sexual relationships, high number of sexual
partners, parity, smoking and another sexually transmitted infection may elevate the rate of
virus infection [6, 18, 19].
Oral HPV can be transmitted by direct skin-skin contact [3] and self-inoculation [1, 4]. Upper
airway transmission has not yet been established [8].
Infant HPV is mainly transmitted at birth by infection of the maternal cervix. Thus, the
recurrent laryngeal papillomatosis seems to be acquired by such manner [19, 20]. However,
another transmission route is mother-fetus, before, during or after the child-birth [1, 4, 8] that
may be made possible by infected amniotic fluid and umbilical cord blood [21].
The transmission of HPV through fomites may also occur [22].
4. Risk and protective factors
In the social sphere, people who have yet to initiate sex life have a low probability of HPV
infection. On the other hand, people who started their sex life earlier or have a promiscuous
sexual life are more likely to have sexually transmitted infections, including HPV. In the
economical sphere, it has been found that low levels of HPV infection were strongly related
with higher income levels [4].
Early age initial sexual activity, oral sex, more than one sexual partner, not wearing condoms,
infrequent use of condoms all pose important risks to any sexually transmitted infection, such
as HPV. Homosexuals tend to have greater number of sexual partners than heterosexuals, and
as such, they should be more commonly infected than heterosexuals, but studies have yet to
confirm this trend [4, 8].
Oral HPV Related Diseases: A Review and an Update 19
Smoking may pose a lower risk for infection with high risk oral and oropharyngeal HPV than
it was previously believed probably because the oral mucosa keratinization makes it stronger
against minor traumas and consequently HPV infection. On the other hand, high levels of
alcohol consumption have been linked to a higher risk of HPV positivity, but this association
needs further research in order to be more fully established [68].
Normally, people acquire HPV during their adolescent years, or when they approach their
twenties, when they start their sexual life. An immune competent person can suppress HPV
or even eliminate it, and suppressed HPV may be kept subclinical for years [8].
Among the leading protective factors, saliva stands out. It is composed of lysozymes, lacto‐
ferrin, IgA and cytokines which seems to be the reason behind low HPV transmission through
self-inoculation, oral sex, and the virtually inexistence of transmission through kissing. It has
been suggested that regular consumption of carotenoids would contribute to make HPV
persistence less likely, and a high consumption of folic acid would reduce the risk of HPV
infection [4].
5. HPV associated oral injuries
HPV infection range from asymptomatic to visible lesions, which can be benign or malignant
[6]. The most common oral manifestations are described below:
5.1. Condyloma acuminatum
The lesion is caused by the abnormal proliferation of a squamous stratified epithelium [23].
Formerly it was believed that the only transmission route was by sexual contact, but now it is
known that there are other routes, such as self-inoculation and mother-fetus transmission [15].
However, sexual contact remains the main route of transmission (20%) [23], and people who
carry these lesions and practice oral sex have a 50% chance to acquiring oral condyloma. The
incubation period range from 3 weeks to an undetermined period of time; after that, clinic
progression will depend on cell permissiveness, virus type and host immune situation [24].
Condyloma acuminatum has tropism to tongue, lips, palate and mouth floor. Clinically, it is
described as little pinkish or whitish nodules which proliferate in papillary projections that
might be either pedicle or sessile. Outline surfaces present even more evident cauliflower
shapes than papilloma, mainly when they converge (Figure 1 – A, B).
Histologically, oral condylomata are typically papillary proliferations of squamous epithelium
with prominent acanthosis and parakeratin that line deep crypts, similar to their counterparts
in the lower genital tract. Koilocytosis is the classic diagnostic feature, consisting of cells with
perinuclear halos of various sizes and accompanied by variability in nuclear size and chro‐
maticity, as well as nuclear membrane irregularity. These features are most prominent toward
the surface of the lesion (Figure 1 – C, D) [25].
HPV presence was first determined by immunohistochemistry and later by hybridization with
75 to 85% of positivity [15]. The most involved types are 6 and 11 [5, 15, 18].
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Differential  diagnoses  include  oral  squamous  papilloma,  verruca  vulgaris,  molluscum
contagiosum, seborrheic keratosis, lichen planus and oral squamous cell carcinoma (OSCC)
[15].
Condyloma acuminatum treatment is not always necessary. For 20-30% of HPV patients,
lesions are self-limited and resolve spontaneously within six months, while for 60% of them,
lesions may regress in a year. Relapses affect 20-30% of patients undergoing treatment, and
they may reappear on the same sites or on different locations [24]. The choice of therapy is
based on a range of factors, such as lesions size, aspect, number and sites. Other factors of equal
significance include patient preference, costs, and adverse effects [23]. Commonly, lesions have
been treated by excisional surgery, but in the last years a wider choice of treatments have
become available, e.g., cryotherapy, electro cauterization and CO2 laser. Other options include
caustic agents, such as trichloroacetic acid, podophyllin and 5-flourouacil which may cause
tissue destruction [23].
Figure 1. Condyloma acuminatum. Rose-colored nodule with a cauliflower-like surface in the floor of the mouth (A;
inset – closer view). Lesion on the hard palate (B; inset – closer view). Microscopically, panoramic view of acanthosis
with papillary folds, parakeratosis and elongation of rete ridges (C, D) (HE, Objective 2.5x). Clinical images obtained
from the archives of the Stomatology Specialization at Odontoclínica Central do Exército (OCEx).
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5.2. Verruca vulgaris (Common wart)
Verruca vulgaris, also known as common wart is one of the most common lesions affecting
mainly children [15], but seldom on oral mucosa [6].
It is usually found on lips, hard palate, gingival, and tongue dorsal surface [15], but especially
on lips and tongue [18] (Figure 2 - A, B). Differential diagnoses is made with oral squamous
papilloma and condyloma acuminatum [15, 18].
Figure 2. Verruca vulgaris. Exophytic lesion with hyperkeratotic surface, forming finger projections in the left commis‐
sure of the lip (A, circle). Lesion on the lower lip (B). Microscopically, panoramic view of acanthosis with papillary folds,
hyperortoparakeratosis and elongation of rete ridges (C; HE, Objective 4x). Koilocitosis (D; HE, Objective 20x). Clinical
images obtained from the archives of the Stomatology Specialization at Odontoclínica Central do Exército (OCEx).
Histologically, verruca vulgaris show an almost symmetrical structure, with elongated rete
ridges that are shorter at the periphery than in central area. Thin elongated connective tissue
papillae form papillomatosis. The cryptoform surface shows a conspicuous hyperkeratiniza‐
tion, predominantly composed of orthokeratin. The stratum granulosum is often pronounced,
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particularly in the grooves between the elongated connective tissue papillae. Koilocytes may
be seen. In the connective tissue, some dilated capillaries and a slight infiltration with lym‐
phocytes are usually seen (Figure 2 C, D) [26]
Immunohistochemical methods and hybridization tests showed HPV presence in 43 to 100%
of the studied lesions [15].
Most oral warts are self-limited, and resolve within 2 years. Aesthetic discomfort or bite injuries
induce patients to look for treatment. Some treatment techniques are cauterization, surgical
removal, liquid nitrogen cryotherapy, local hyperthermia, topic 5-fluoracil, CO2 laser, salicylic
acid, squaric acid, interferon and wart material implantation [18].
5.3. Oral squamous papilloma
Oral squamous papilloma (OSP) is a benign tumor that may occur in all ages, but it more
commonly affects adults between 30 and 50 years old [15]. It is mainly related to HPV 6 and
11 [15, 18]. In adults, the lesion is usually located in the oral mucosa, mostly on palate and
tongue, while in children the laryngotracheobronchial complex is a more common site [27].
OSP affects the soft palate, the lingual frenulum as well as the lower lip [15] and the uvula [27],
most often presenting as a single, small lesion smaller than 1 cm, with exophytic growth and
a wide basis or pedicle. On histopathology the pattern of epithelial proliferation repeats
features described in the previous lesions, with squamous cell acanthosis, hyperkeratosis and
a centrally disposed fibrovascular core.(Figure 3 – A, E). Koilocytosis may be present or not.
Oral squamous papilloma may be isolated or multiple-recurring, which is more likely to affect
immunosuppressed patients, such as HIV-positive patients. Multiple-recurring papilloma is
also more likely to be malignant [27] and tends to relapse more often [28]. Differential
diagnoses include exophytic carcinoma, verrucous carcinoma and condyloma acuminatum
[27]. Surgical removal is the first choice of treatment, but electrocauterization, cryosurgery and
interferon injections are other effective treatment courses [8].
5.4. Focal epithelial hyperplasia (Heck disease)
Focal epithelial hyperplasia (FEH) or Heck disease was first described in 1965 [15] and can
affect all age groups [29], but it is more common in children and adolescents (3 to 18 years) [30].
Malnutrition, poor hygiene and low social condition as well as genetic background also play
an important role [31] in lesion development.
FEH shows a benign epithelial growth and commonly affects oral mucosa, lips, tongue [18],
particularly the lower lip and more rarely the palate, floor of the mouth and oropharynx [30].
Clinically it presents as multiple papules (3 – 10 mm) [30] that tend to converge. They are
characteristically nodular, sessile, circumscribed, painless and soft masses on oral mucosa.
Color may range from pale pink to normal mucosa [15, 29- 31]. (Figure 4 – A, B). The diagnosis
is both clinical and histological [30, 32].
Microscopically it shows epithelial hyperplasia, acanthosis, mild parakeratosis and anasto‐
mosing rete ridges. Superficial layers of the epithelial tissue contain cytophatic changes
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(koilocytosis) and apoptotic or dyskeratotic cells with an apparent mitotic appearance
(mitosoid cells) (Figure 4 – C, D) [30].
FEH has a steady association with HPV infection, and the most common types are 13 and 32
[15, 29]; they account for approximately 90% of infections [30, 32]. HPV-32 might be found in
other type of lesions, but never out of the oral region [15]. Both HPV-1 and 11 are rare and
show potential for malignancy. So far, the only malignant transformation reported has been
found with HPV-24 [32].
Differential diagnoses include condyloma, viral warts, neuroma, white sponge nevus, oral
papillomatosis, [30] and inflammatory fibrous hyperplasia.
FEH normally regresses spontaneously in a few months or years, but it can take longer [30].
Thus, treatment is often chosen to mitigate aesthetic problems or repeated bite injuries [31].
The most effective methods are surgical excision, electrocoagulation, cryotherapy [31], CO2
laser and interferon [30].
5.5. Oral lichen planus
Oral lichen planus (OLP) is a common chronic immunomediated disease [18, 33, 34] of
unknown etiology seemingly related to HPV in some lesions [18], affecting the skin and the
Figure 3. Oral squamous papilloma. Exophytic lesion with hyperkeratotic whitish surface, forming finger projections
on the dorsum of the tongue (A-B). Lesion on the inferior surface of the tongue (C). Lesion on the lower lip (D). Micro‐
scopically, panoramic view of acanthosis with papillary folds, hyperortoparakeratosis, elongation of rete ridges and a
centrally disposed fibrovascular core (E; HE, Objective 2.5x). Clinical images obtained from the archives of the Stomatol‐
ogy Specialization at Odontoclínica Central do Exército (OCEx).
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mucosa [33-, 35]. OLP prevalence ranges from 0, 5% to 4% [35] and mainly affects the female
population [33-35]. The most prevalent age is between 30 to 60 years old, although occurrence
in children and adolescents seems to be on the rise [35]. In around 15% of the cases the skin is
affected and this number increases to around 85% of cases affecting the mucosa, particularly
the oral and genital mucosa. The oral mucosa is affected in 20% to 30% of the cases. Besides
being more common, OLP is more resistant to treatment than skin OLP [34]. A possible
relationship between OLP to Hepatitis C has been hypothesized, but it has not been clearly
established.
Diagnoses depend on clinic manifestation as well as histopathology results [35]. OLP lesions
are usually bilateral and symmetric affecting areas the oral mucosa, gingiva as well as the
dorsum of the tongue and the lip mucosa (Figure 5 – A, F ).
The lesions may be single or multiple and may present in a wide range of forms- cauliflower-
like, striated or annular. Long-time evolution of a lesion is usually atrophic, and when the
lesion is located on the tongue it may cause papillae loss and modify gustation (Figure 5 – G,
F ). Extensive lesions are also more painful [35].
Figure 4. Focal Epithelial Hyperplasia. Multiple flat and coalescent papules on the lower lip mucosa (A-B). Microscopi‐
cally, panoramic view showing acanthosis and irregular elongation and anastomosis of rete ridges (C; HE, Objective
2.5x). Classic “mitosoid” figure (D; HE, Objective 40x). Clinical images obtained from the archives of the Stomatology
Specialization at Odontoclínica Central do Exército (OCEx).
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Figure 5. Oral lichen planus. Most prominent features are bilateral white striae in buccal mucosa, with certain symme‐
try (A-B). Gingiva may also be affected (C-D) (*) and it may show atrophic symptomatic spots surrounded by Wickham
striae (arrows). When it affects the tongue, it is not as typical (E-F) and may be confused with oral leukoplakia or
smoker’s tongue. Microscopically a strong sub epithelial lymphocytic infiltrate should be present (C; HE, Objective
10x), in association with degeneration of the basal layer (D; HE, Objective 20x) and absence of epithelial dyspla‐
sia..Clinical images obtained from the archives of the Stomatology Specialization at Odontoclínica Central do Exército
(OCEx).
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According to Silverman’s classification OLP may be presented as reticular, erosive and
atrophic forms [33]. Each form has its different clinic evolution and determines different
intensity and duration, with the possibility of evolving from one form into another [35].
On histopathology, we may find acanthosis in keratotic lesions, and atrophy in older lesions.
Two important findings are hydropic degeneration of the basal layer, as well as a strong
subepithelial lymphocytic infiltrate (Figure 5 – G, H). Those lesions that present dysplasia
should not be classified as OLP [36, 37]. Biopsy should be preferably performed on keratotic
areas, however this might be a complicated intervention when the patient has extensive oral
candidiasis [34, 35]. Some other pathologic entities may present similar histopathologic
features, such as lichenoid reaction, which is similar to lichen planus, but usually is related to
amalgam fillings or certain medicines [33, 34].
The most prevalent and commonly found HPV types are 11 and 16 [18].
The conditions that may be considered as differential diagnosis of OLP include the reticular
form which should be distinguished from systemic lupus erythematosus, candidiasis,
traumatic lesions, secondary syphilis, hairy leukoplakia and incipient OSCC. The erosive form
should be distinguished from aphthae, mucous membrane pemphigoid, pemphigus vulgaris,
drug reaction, polymorphic erythema and systemic lupus erythematosus acute lesions [35].
Malignant transformation is reported for OLP, however, a current tendency is to consider
those lesions that do not fulfill established clinical and pathologic criteria for OLP as oral
lichenoid lesions. These lesions mimic OLP and would be the ones truly at risk of becom‐
ing a OSCC [36, 37].
Treatment does not assure cure, for unknown reasons, but it does reduce symptoms, particular
when they are severe, atrophic and widespread. Unlike the asymptomatic reticular form,
erosive lesions need prompt symptomatic treatment. Oral hygiene reduces inflammatory
lesions and topic corticosteroids may be used in the form of mouth wash. Calcineurin inhibitor,
a topic immunosuppressive agent, and topic retinoid, such as imiquimod, are other treatment
options, with the latter being used together with topic corticosteroids [33-35].
5.6. Oral leukoplakia
Leukoplakia is considered a premalignant lesion or potentially malignant disorder on oral
cavity, and reported rates of development into malignancy vary widely depending on the
method of diagnosis and definition criteria used for oral leukoplakia [38]. The most common
malignant transformation is into oral squamous cell carcinoma (OSCC) [38, 39], with percen‐
tages ranging from 3 to 37% [38].
Oral leukoplakia prevalence ranges from 0, 4 to 0, 7%, and there is no variability related to
gender. However, some researchers believe that prevalence among women is higher [38].
Etiology is uncertain; however smoking along with alcohol consumption is pointed as the main
risk factors. There are possible cofactors, such as candidiasis, HPV and more recently Epstain-
Barr virus (EBV) has been associated with these lesions in imunossupressed patients [38]. EBV
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rarely affects immunocompetent people and it does not need a specific treatment [40].
Treatment should address the underlying cause of immunosuppression.
Oral leukoplakia may be located on lip vermillion, gingival, tongue and floor of mouth, and
it is on these latter regions that there is a higher risk of malignancy (around 43%) [38, 40]. Oral
leukoplakia distribution may be local or disseminated [41] (Figure 6 – A, F).
Figure 6. OL: Oral leukoplakia. OL located at lateral (A-B) and ventral tongue show higher risk for malignant transfor‐
mation. These lesions may be homogenously white (A), or associated with ulcers (B). Other common location is gingi‐
va (C-D), floor of mouth (E) and alveolar ridge (F) and a traumatic cause or association with candidiasis should be ruled
out before biopsy. Microscopically leukoplakia can demonstrate only epithelial hyperplasia with acanthosis and hyper‐
parakeratosis (G; HE, Objective 4x), without dysplasia (H; HE, Objective 20x). In this case inflammatory infiltrate was
scarce. Clinical images obtained from the archives of the Stomatology Specialization at Odontoclínica Central do Exército
(OCEx).
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Histological examination reveals a range of epithelium changes varying from innocuous
hyperplasia to dysplasia of varying degrees [18]. However, more commonly, OL presents
hyperkeratosis and epithelial hyperplasia without dysplasia [38] (Figure 6 – G, H). Depending
on the dysplasia degree, it may be classified as low, intermediate and high risk of malignancy
[38], so that severity of the dysplasia is the key standard in malignancy prediction [39].
However, diagnosis of dysplasia is rather subjective and as such it is highly dependent on the
pathologist/researcher [38, 39]. Another controversial issue is that it is virtually impossible to
accurately predict which lesion, even among those with dysplasia, will develop into a
malignant one [39]. Rather, we might get to know which lesion is more likely to become
malignant, if clinic and histological characteristics are analyzed in association [38.37]
Viral etiology is unclear. Although HPV 6, 11 and 16 have been predominantly found, and also
HPV 18, 31, 33, 35 [18, 38] in lesions, the viral etiology remains controversial. It seems that
lesions which contain HPV are less malignant than oral leukoplakia in smokers, similar to what
happens in OSCC. HPV-16 is present in 80% of the lesions, regardless of malignancy [5], and
it has already been established that type 16 is related to OSCC in nonsmoker or nondrinkers.
EBV seems to be an etiologic factor of oral leukoplakia because it appears in a great number
of malignant lesions in imunossupressed patients [38]
Differential diagnoses are leukoedema, white sponge nevus (Cannon's disease), contact
dermatitis lesions, chronic biting, nicotinic stomatitis, OSCC, oral hairy leukoplakia, verrucous
carcinoma, OLP and secondary syphilis.
There has not been any agreement as to the best treatment course, and prevention (smoking
and drinking avoidance and a diet rich in fruits and vegetables) remains the best approach. A
topical treatment based on topical bleomicyn and systemic retinoid is used as an effective short
term treatment, however there are doubts as to its long term efficacy. Invasive treatments
include cryosurgery, CO2 laser, and surgical resection. They are effective in the short run, but
lesions may relapse in the long run [38, 42]
5.7. Oral verrucous carcinoma
Oral verrucous carcinoma (OVC) is a squamous cell carcinoma (SCC) subtype [15, 43, 44], but
it shows a much more benign behavior, with well distinguished morphology and clinical
presentation. It is located on the head, neck and genitals, and more notably on the oral mucosa,
and it has low probability of metastasis [43, 44].
OVC is a rare tumor and had been described by Ackerman [15, 43, 44] in 1948 as a cancer that
involves the lips, oropharynx and laryngeal mucosa. It is also known as Ackerman’s tumor.
However, the condition has also been referred as florid oral papilomatosis, epithelioma
cuniculatum, carcinoma cuniculatum and also as Buschke-Loewestein tumor [43]. Nowadays
carcinoma cuniculatum is considered as a separated pathologic entity [45].
The etiopathogenesis of OVC is unknown, but some studies have found associations mostly
with smoking, some alcohol ingestion and infection by HPV [15, 44]. OVC related co-factors
are poor oral hygiene, OLP or the presence of leukoplakia lesions. HPV may have an important
role in tumor development and progression, but further research is necessary [44].
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HPV has been widely described as one of the causes of OVC, and the most commonly found
types are 6, 11, 16 and 18, which were identified by polymerase chain reaction (PCR), restriction
fragments analyses and DNA slot hybridization [44].
Oral verrucous carcinoma is a male disease and affects predominantly the 50-80 age group [44].
OVC is characteristically situated on the oral mucosa, gingiva, mandible alveolus crest, tongue
and lips [44].
It appears with slow exophytic growth, resulting in verrucous cauliflower lesions, with white
plaques, normally extensive and with well demarcated hyperkeratotic lesions [15, 43, 44]. It is
well circumscribed, invasive only on surface, with low probability of metastasis [43] (Fig‐
ure7 – A, C). People usually look for doctors because of the extensive rapid growth, which
scares them.
OVC histology is characterized by the presence of acanthosis and keratinization with keratin
plugging  and  clefting  [43,  44].  They  are  irregular  and  may  extend  into  cleft.  Atypia  is
minimal  and  usually  there  is  inflammatory  infiltrate  on  the  subepthelial  layer  around
epithelial invaginations which seem to compress the underlying tissue (“elephant feet”) [44]
(Figure 7 – D, E).
Figure 7. Oral verrucous carcinoma of the lip mucosa. Typical clinical presentation showing an indolor sessile nodule
with a white verrucous surface (A,B). Surgical excision was performed resulting in an excellent esthetic and functional
outcome (C). Microscopically, evident hyperkeratosis is observed, with epithelial acanthosis and invasion as pushing
borders towards the stroma (D). Minimal epithelial atypia is seen along with a strong lymphocytic infiltrate (E). Images
obtained from the archives of the Stomatology Specialization at Odontoclínica Central do Exército (OCEx).
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Main OVC differential diagnosis is verrucous hyperplasia, which is very similar, clinically and
histologicallly. Verrucous hyperplasia has in fact been regarded as an OVC precursor [43].
Other differential diagnoses are OLP, benign keratosis, chronic candidiasis, verruca vulgaris,
oral leukoplakia, reactive keratosis epithelial hyperplasia, pseudoepitheliomatous hyperpla‐
sia. It is difficult to distinguish OSCC from OVC, because they may share a similar clinical
picture and incisional biopsy excerpts may not contain atypias [44].
Besides that, tumors mainly composed of OVC may contain small areas of OSCC and behave
as one. Ideally, for definitive diagnosis the entire tumor mass with its surrounding tissue
should be excised and sent for histopathologic analysis [43].
The treatment main option is surgical resection [15, 46] that may be associated with radiother‐
apy particularly on larger lesions. Relapse rate is high when surgical resection or radiotherapy
is performed in isolation. Prognosis of OVC is better than for other types of tumor. Cytostatic
drugs, such as α- interferon (IFN), should be considered for patients who cannot undergo
surgery, but results are not superior from those obtained with surgery [46].
5.8. Oral Squamous Cell Carcinoma (OSCC)
OSCC is a worldwide problem [47], representing approximately 3% of all malignant neo‐
plasms; which means more than five thousand diagnosed cases a day [48], and more than 90%
of all oral cancers [49].
It is a condition primarily related to environmental factors [8] and lifestyle as heavy smoking
(more than a pack a day) and drinking (more than 100g a day) [47]. These two are the main
risk factors for malignant epithelial transformation. Other risk factors include compromised
immune system, poor buccal hygiene and inadequate eating habits [47, 49]. However, OSCC
may affect 15 to 20% of patients with no known risk for the condition [8].
Friedrich et al. reported a 20% to 30% HPV association with OSCC [50]. A meta-analysis
indicates that oral infection with HPV is an independent risk factor for OSCC. [51] Typically,
elderly people [47, 49] are more affected than young people. However, the incidence in young
adults is increasing. Some studies have shown that OSCC in young adults follow a different
clinical course, being more aggressive and affecting more males [47]. On the other side, other
authors have shown no difference in survival among elderly and young adults with OSCC [52].
The most commonly affected site for OSCC is the tongue, especially on inferior and lateral
surfaces (40%) [53](Figure 8 – A, F), but it can also affect buccal mucosa, lips, posterior
mandibular ridge, gingiva, hard palate and retromolar trigone [47, 49, 53, 54].
The clinical picture may vary among OSCC types. Typically they are nodular or ulcerative
lesions [15, 18], with exophytic or ulceroproliferative features [47]. At more advanced stages
lesions present an ulcerated center, not well defined with hard borders. At this point, symp‐
toms such as loss of teeth, bleeding, dysarthria, dysphagia, odynophagia and otalgy may
develop [54].Some of them, for unknown reasons, do not progress into metastasis, while others
infiltrate quickly, invading the lymph nodes [55]. Tongue and floor of the mouth tumors invade
cervical lymph nodes in up to 25% of initial stage cases [56, 57] and are often submitted to
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elective neck dissection. Cervical metastasis at diagnosis is the main indicator of a bad
prognosis [45].
Figure 8. Clinical aspect of OSCC. It may present as an exophityc nodule, ulcerated (A-B) or not (C). It can also be de‐
tected as a small induration interspersed in a white plaque (D - arrow). It may show intra osseous invasion (E), with a
strong white component, and reach distant sites (F) from the initial spot. Images obtained from the archives of the
Stomatology Specialization at Odontoclínica Central do Exército (OCEx).
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Histologically a range of features may be present, but it is important to detect epithelial
invasion in the stroma, that may occur as islands, cords, sheets and isolated epithelial malig‐
nant cells. Keratin may be present, mostly in well and moderately differentiated tumors. There
are varying degrees of atypia, nuclear and cellular pleomorphism with aberrant and regular
mitosis (Figure 9 – A, D). Usually poorly differentiated tumors are related to recurrence [58].
Clinic and histological features are important to determine treatment, prognostic factors and
survival rates [58, 59]. There is a TNM staging scheme, for OSCC and salivary gland tumors
[60]. At the initial stages survival rates reach 80%, while at more advanced stages they decrease
to 21% [54].
Figure 9. OSCC histopathology. It is possible to observe superficial non affected oral epithelia and tumoral islands in
the stroma (A; HE, Objective 4x). A closer view of the tumoral islands with central keratin (B; HE, Objective 10x). Pleo‐
morphism and atypia are observed (C; HE, Objective 10x), as well as mitosis (*) and intercellular bridges (D; HE, Objec‐
tive 20x).
A correlation between HPV and cervical SCC of the utherus has been identified, but despite
the strong evidence of HPV presence, there is no clear-cut proof that would point to HPV as
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an isolate SCC cause on oral cavity. Some studies argue that HPV is a mere supporting causer
[1, 61] while another study indicates that tumors positive for oncogenic types of HPV may
show better survival [62], mainly in oropharynx, where HPV positive tumors are associated
with a specific morphology (basaloid squamous cell carcinoma, a subtype of conventional
carcinoma) and positivity for p16 using immunohistochemistry [63].
HPV-16 has been found in 90% of head and neck cancers and in 50% of oropharynx [1, 18, 53,
64]. However, some authors have not found such association [64].
Potentially malignant disorders such as leukoplakia, erytroplakia, proliferative verrucous
leukoplakia and lichen planus may progress to OSCC [1] and upon biopsy, there may be
already areas of an actual OSCC [65].
Surgical resection is the treatment of choice when the lesion is placed on oral cavity while
chemoradiotherapy is used when the oropharynx is the afflicted site [22] or if it is a tumor in
a very advanced stage [66].
Surgery may impair some functions as speech, swallowing, and chewing and abruptly change
quality of life. To maintain swallowing and speech, an alternative course is ablative surgery
(microvascular free tissue), but this is not regarded to be as effective as surgical resection. In
advanced stage when metastasis is located on upper aerodigestive tract, treatment should be
multimodal, combining surgery and chemoradiotherapy [46].
Recurrent OSCC is challenging as the risk of complication is increased due to fibrosis and tissue
hipovascularization [51].
Radiotherapy may be primary, adjuvant or neoadjuvant. It is regarded as primary for unre‐
sectable tumor or for patients who cannot undergo surgery, adjuvant as a post-surgery
complementary method, and neoadjuvant when performed before surgery to facilitate tumor
resection [54].
6. HPV oncogenic potential
HPV infection may lead to cell immortalization by means of infection of the mucosa and skin
basal epithelial cells, which are the only ones that keep in the cell cycle [8, 61]. It may be by
itself a causative agent of malignant transformation or when associated with other unclear
cofactors [61]. However, some researchers have argued that HPV is not able to cause malignant
transformation, despite the studies which point to the contrary [12].
Some factors should come into play to immortalize cells: virus type, synergetic action among
physics, biological and chemical agents and genetic constitution, which are able to modify the
natural course of the disease. But if the exposed person has a favorable condition and acquires
high risk HPV it becomes easier to integrate viral DNA into human genome [61].
Oral HPV has been diagnosed in OSCC and it is believed that it has been involved in oral
carcinogenesis by transforming the keratinocytes through a mechanism involving E6 and E7
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proteins. However, the mechanisms behind immune response against high risk HPV remain
unclear [67-69].
7. HPV detection methods
The identification of various types of HPV is a recent technological advance due to the growth
impossibility in tissue cultures and research animals.
Diagnoses methods vary from simple to sophisticated ones, ranging from light microscopy to
DNA expression, with low to high sensitivity. Light microscopy and in situ hybridization are
considered low sensitivity methods because it only tests positive when there are more than 10
viral DNA copies per cell. Among the intermediate sensitivity methods we find southern blot,
do blot and reverse hybridization with a positive detection result when there is from 1 to 10
DNA copies per cell. High sensitivity methods, such as PCR, needs less than 1 viral DNA copy
per cell for microorganism detection [70].
7.1. Light microscopy
This method provides some data, even though it has low sensibility and it does not inform the
HPV type. The most common HPV induced changes are epithelial thickening, prominent
keratohyalin granules, hyperkeratosis, nuclear dysplasia, hyperchromasia, double nucleation
of superficial and intermediated cell, perinuclear cytoplasmic halos, and atypical immature
metaplasia [9].
7.2. Electron microscopy
HPV particles may be identified by electron microscopy (EM), but not the HPV type. EM can
detect the presence of virion on koilocytic and dyskeratotic cell nuclei, but it is a limited method
to investigate infection, because high risk HPV do not reproduce and as such cannot be
identified through EM [5].
7.3. Molecular methods
Molecular methods can be divided into two types: non-hybridization, such as in situ amplifi‐
cation, southern and dot blot hybridization and the amplified, such as target amplification,
signal amplification and probe amplification. Target amplification is best exemplified by PCR.
Signal amplification may be represented by hybrid technique sample. Probe amplification
which is a compound-probe is added to a probe generating signal (Ligase Chain Reaction)
according to literature [5].
7.4. In Situ Hybridization (ISH)
In situ hybridization using biotinylated probes is a common method for detecting HPV in oral
epithelium. It is practical and economical for screening for HPV in clinical pathology labora‐
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tories. In situ hybridization also permits direct comparison of viral DNA location with
histologic morphology [9, 71]. Although this technique is highly sensitive in cases in which
individual nuclei contain a high copy number of the target DNA, as is likely to occur in most
active infections, the method of ISH often fails to detect cases in which subgenomic fragments
of the viral DNA have been incorporated into the host genome and the infection is nonpro‐
ductive of intact viral particles. So when there is low viral DNA amount, it leads to low
sensitivity [71, 72]
7.5. Southern blot and dot blot hybridization
Southern Blot classifies and identifies new viral types. It is a labor-intensive process that
requires well trained skills and depends on a new generation of equipments. This technique
requires the total length of a DNA molecule, and offers additional information about viral
integration and subtype [70].
Dot blot is a simplified southern blot, requiring less sophisticated facilities, but it is rarely
performed because of its low sensitivity. It is often used as detection kits available on the
market [70].
7.6. Target amplification
The classic example of target amplification is PCR. This is the best subtype detection method
due to the high sensitivity [9]. It is commonly used as diagnostic tool for HPV DNA epide‐
miological investigation, but because of the high cost this method cannot be used in a routine
clinical practice. PCR has a high sensitivity and it is very effective for both malignant and pre
malignant lesions identification, and material can be collected with oral swab or wash [7, 9].
7.7. Hybrid Capture technology (HC)
Using signal amplification with microplate chemiluminescent detection, this method identifies
nucleic acid due to its high sensitivity [9]. HC is a very important tool to detect high risk HPV,
and the method has identified HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 types [9]. This
technique is able to identify 5000 viral copies per sample [73].
7.8. Probe amplification
Probe  amplification  methods  differ  from  target  amplification  in  that  the  amplification
products contain a sequence only present in the initial probes. It is used currently as an
important diagnostic application, the detection of high-risk genotypes of human papillo‐
ma viruses (HPV) [74].
7.9. Education and vaccine prophylaxis
One simple and effective prophylactic measure is patient education. It must be clear to patients
that even after treatment the virus remains on the oral mucosa, so it is imperative to maintain
good oral hygiene, condom use in all sexual relations and refrain from promiscuous sexual
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behavior. Clinical examinations have to be done periodically and smoking and chronic
alcoholism must be abolished.
It is crucial that the population in general be informed about HPV prevention as a control
strategy and early diagnosis promotion. Raising awareness of HPV through education is
essential to develop population perception about risk factors, mainly those related to sexual
activity[18]. It is also important to discourage early sexual initiation [69].
In view of the increasing figures of cervix cancer, the US Food and Drugs Administration (FDA)
approved in 2006 a vaccine against HPV [75]. There is a bivalent vaccine that contains L1
HPV-16/18 protein which generates a huge number of genotype specific antibody [75]. For
HPV 16/18 vaccine efficiency is round 96% on cervix cancer [69]. There is also a tetravalent
vaccine that works in the same way as the bivalent, but provides further immunity enclosing
HPV types 6, 11, 16, 18 [75]. Both of them use virus- like particles in their composition [9].
The vaccine(s) stimulates humoral response, but it also stimulates B cell immune memory
response, which persists for five years [69]. After a 5 years follow up, it has demonstrated 100%
of efficacy on persistent infection prevention [8].
As HPV’s physiopathology is very similar on the affected sites, whether they are the skin,
cervix, penile, anus or oral mucosa, there is no reason to doubt that the vaccine which works
well on the cervix would also prove effective for the prevention of oral mucosa lesions [75].
As HPV-16 seems to be an important risk factor for the progress of malignant lesions (because
it is found in most OSCCs), it might be possible that the vaccine would prevent or even treat
them [8].
HPV vaccine seems to be less effective on women who have already been exposed to the virus,
hence the public health focus on vaccinating girls before their first sexual relation to prevent
warts and more disaster lesions in the future [8, 9]. Some countries have promoted vaccination
for any females from 9 to 26 years who have never had sexual experience before [76]. Other
countries promote vaccination for females up to 45 years old [77]. Vaccines for men aged 11
up to 26 years old in order to prevent genital warts and anal cancer was approved in 2011 by
the US Advisory Committee on Immunization Practices [78].
HPV is as frequent in men as in women; however, it is often asymptomatic in males, what
makes them a HPV reservoir to cervix and non- cervical lesions in females, transmitted mainly
by sexual activity [69]. Current studies have been done in order to further assess the natural
history of the HPV infection in men [79, 80].
A therapeutic vaccine is under study, one which could be used as adjuvant on surgery or
radiotherapy, to clean up microscopic waste of the lesion, thus generating immune response.
In view of the potential risks of HPV and the potential benefits of the vaccine (some not yet
fully established) some researchers favor the extended use of the vaccine to all age groups of
both sexes, regardless of previous sexual practice, as a form to interrupt the transmission cycle
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and as a preventive strategy in controlling and avoiding the risks posed by HPV, including
various types of cancer in different locations in the human body.
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